Drug Shortage Report for COMBIVENT UDV

Last updated on 2017-04-06 History
Report ID 2178
Drug Identification Number 02231675
Brand name COMBIVENT UDV
Common or Proper name COMBIVENT UDV
Company Name BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Market Status CANCELLED POST MARKET
Active Ingredient(s) IPRATROPIUM BROMIDE SALBUTAMOL
Strength(s) 0.2MG 1.0MG
Dosage form(s) SOLUTION
Route of administration INHALATION
Packaging size 20 x 2.5ml
ATC code R03AL
ATC description ADRENERGICS, INHALANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-01-11
Estimated end date 2017-04-24
Actual end date 2017-04-05
Shortage status Resolved
Updated date 2017-04-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5180 SOUTH SERVICE ROAD
BURLINGTON, ONTARIO
CANADA L7L 5H4
Company contact information 1800 263 2425

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-03-14 English Compare
v2 2017-03-14 English Compare
v3 2017-03-14 French Compare
v4 2017-04-05 English Compare
v5 2017-04-05 French Compare
v6 2017-04-05 English Compare
v7 2017-04-05 French Compare
v8 2017-04-06 English Compare

Showing 1 to 8 of 8